<DOC>
	<DOCNO>NCT01929720</DOCNO>
	<brief_summary>This randomize clinical trial study cognitive-behavioral intervention treat worry , uncertainty , insomnia cancer survivor . Counseling may reduce anxiety insomnia well improve well-being quality life cancer survivor . This study also explore neuro-immunologic correlate anxiety insomnia .</brief_summary>
	<brief_title>Cognitive-Behavioral Intervention Worry , Uncertainty , Insomnia Cancer Survivors</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To complete randomize pilot trial cognitive-behavioral anxiety-insomnia intervention determine impact intervention patient worry , intolerance uncertainty , sleep efficiency . II . Explore underlying endocrine immune mechanism responsible specific symptom cluster ( anxiety-insomnia-depression-pain-fatigue ) observe among advanced cancer patient . OUTLINE : Patients randomize 1 2 treatment arm . ARM I : Patients wear wrist actigraph , collect saliva sample , complete sleep diary worry record daily week 1 5 . Patients also receive education component anxiety ( physical cognitive , behavioral ) practice relaxation technique behavioral sleep strategy week 2-5 . Blood draw optional . ARM II : Patients wear wrist actigraph , collect saliva sample , complete sleep diary worry record daily week 1 5 . Blood draw also optional . This wait-list control arm , patient arm , six-week period treatment usual oncologist , receive intervention .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<criteria>lung cancer stage III IV colorectal cancer pancreatic cancer esophageal cancer multiple myeloma leukemia stage IIIC IV melanoma ovarian cancer stage III &amp; IV cervical cancer stage III &amp; IV uterine cancer stage IIIB , IIIC , IV breast cancer glioblastoma multiforme early relapse ( &lt; 1 year ) lymphoma comorbid immunologic disease ( i.e . rheumatoid arthritis , systemic lupus ) neurologic disease ( i.e . multiple sclerosis , Parkinson 's , Alzheimer 's ) would affect neuroimmune assessment completion study questionnaire mania ( patient bipolar disorder ) active substance abuse disorder alcohol dependence cocaine abuse also exclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>cancer</keyword>
	<keyword>cancer survivor</keyword>
	<keyword>worry</keyword>
	<keyword>insomnia</keyword>
	<keyword>symptom</keyword>
	<keyword>fatigue</keyword>
	<keyword>depression</keyword>
	<keyword>anxiety</keyword>
</DOC>